TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that on May 7, 2008 it was notified by the Nasdaq Listing Qualifications Department that EpiCept has not regained compliance with the continued listing requirements of The Nasdaq Capital Market because the market value of EpiCept’s listed securities fell below $35,000,000 for ten consecutive trading days (pursuant to Rule 4310(c)(3)(B) of the Nasdaq Marketplace Rules). As a result, its securities are subject to delisting from The Nasdaq Capital Market.
